Biotecnología

Biotecnología

FDA Roundup: February 13, 2024
22/02/2024 - The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Quantum leaps in aging research: an interview with Peter Fedichev
22/02/2024 - In this interview we speak with Peter Fedichev (Gero; CA, USA) about AI-driven drug discovery in aging research. Peter explains more about the use of quantum computing in drug design, and...
ValGenesis & RxCloud Join Forces to Enhance Life Science Quality & Compliance
22/02/2024 - Aim to help life sciences companies meet regulatory requirements and standards for quality and safety in the drug development and manufacturing life cycle.
Azzur Group Introduces Analytical Laboratory Testing Services
22/02/2024 - Aims to enable industry pioneers in the delivery of novel cell and gene therapies.
MedWatch: The FDA Safety Information and Adverse Event Reporting Program
22/02/2024 - MedWatch is made up of voluntary and mandatory reporting on prescription medicines, over-the-counter medicines, non-vaccine biologicals, medical devices, special nutritional products, cosmetics and...
VantAI, BMS Partner to Accelerate Molecular Glue Drug Discovery
22/02/2024 - Will leverage VantAI's geometric deep learning capabilities with Bristol Myers Squibb’s expertise in targeted protein degradation.
Resilience Expands Clinical & Commercial Drug Product Manufacturing Capabilities
22/02/2024 - Aims to address the biomanufacturing industry’s growing demands within the drug product space, further responding to industry needs.
Watch out spiderman! We’ve found a way to create spider silk
22/02/2024 - Scientists from the RIKEN Center for Sustainable Resource Science (Wak?, Japan) have crafted a device capable of spinning artificial spider silk...
Vetter Successfully Commercializes 8 Customer Drug Products
22/02/2024 - Brought eight customer drugs to market after supporting them through the development phases.
Evonik, University of Mainz Partner on Drug Delivery
22/02/2024 - Aim to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs.
AI-driven screening could improve health equity for youth with diabetes
22/02/2024 - AI technology is taking the lead in transforming diabetes care, particularly in the realm of eye examinations, according to an intriguing study from Johns Hopkins Children's Center...
Telix to Acquire QSAM Biosciences and Lead Investigational Drug
22/02/2024 - 53Sm-DOTMP is aligned with Telix’s existing therapeutic focus areas in urologic oncology, neuro-oncology, and musculoskeletal oncology.
$31M Awarded: Ginkgo & SaponiQx to Develop Next-Gen Vaccine Adjuvants
22/02/2024 - Aim to use a combination of high-throughput empirical and AI/machine learning approaches to develop novel saponin-based adjuvants.
Abzena Launches LabZient Analytical Platform
22/02/2024 - Aims to streamline the assessment and validation of large molecules, thereby reducing drug development timelines and resource costs.
Two drugs after our own hearts: preventing cardiac fibrosis
22/02/2024 - Scientists at the University of Virginia (UVA) (VA, USA) have harnessed the power of machine learning to identify a potential breakthrough drug that could mitigate harmful scarring...
INCOG BioPharma Boosts Filling Capacity with New OPTIMA Line
22/02/2024 - Will complement the company's existing multi-use filling line, bringing the company's total filling capacity to 140 million units per year.
Vaccines and Related Biological Products Advisory Committee March 5, 2024 Meeting Announcement - 03/05/2024
22/02/2024 - This is the main page for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) March 5, 2024 Meeting announcement and meeting materials.
Practicing house decluttering with virtual reality
22/02/2024 - Stanford Medicine (CA, USA) researchers have pioneered a virtual reality...
FDA Roundup: February 20, 2024
22/02/2024 - The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
FDA Approves Takeda’s EOHILIA in EoE
22/02/2024 - Study shows significantly more patients receiving EOHILIA achieved histologic remission vs. placebo.
Una aplicación móvil con IA ayuda a evaluar patologías cutáneas
22/02/2024 - La Organización Mundial de la Salud estima que las afecciones cutáneas, que pueden ser de origen bacteriano, vírico, fúngico o parasitario, afectan a 1.800 millones de personas. En entornos...